Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT Tome to present data at ASGCT.

Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration Tome granted US patent for programmable genomic integration.

Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).

Tome Lights Up Generative Storytelling with New DALL·E 2 Integration SAN FRANCISCO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Tome, the new storytelling format for work and important ideas, today announced an integration with OpenAI text-to-image generator DALL·E 2. The news...

Tome Restacks the Deck with New Storytelling Tool For Work SAN FRANCISCO, March 23, 2022 (GLOBE NEWSWIRE) -- Tome launched today as the modern storytelling tool for work. Tome is built for people to express themselves intuitively so they can stop designing...